AG0037DR

312636-16-1 | 4-[[4-(4-Chlorophenyl)-2-thiazolyl]amino]phenol

AG0037DR

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	312636-16-1
Catalog Number	AG0037DR(AGN-PC-0JVXKW)
Chemical Name	4-[[4-(4-Chlorophenyl)-2-thiazolyl]amino]phenol
IUPAC Name	4-[[4-(4-chlorophenyl)-1,3-thiazol-2-yl]amino]phenol
InChI	InChI=1S/C15H11ClN2OS/c16-11-3-1-10(2-4-11)14-9-20-15(18-14)17-12-5-7-13(19)8-6-12/h1-9,19H,(H,17,18)
InChI Key	ZFGXZJKLOFCECI-UHFFFAOYSA-N
MDL Number	MFCD00733553
Molecular Formula	C15H11ClN2OS
Molecular Weight	302.7786
SMILES	ClC1=CC=C(C=C1)C=1N=C(SC1)NC1=CC=C(C=C1)O
Synonyms	4-((4-(4-chlorophenyl)-2-thiazolyl)amino)phenol, SK I-II compound, SKI II, 312636-16-1, 4-[[4-(4-Chlorophenyl)-2-thiazolyl]amino]phenol, SphK-I2, SKIII, SKI-II, 4-(4-(4-chlorophenyl)thiazol-2-ylamino)phenol, Sphingosine Kinase Inhibitor 2, 4-{[4-(4-chlorophenyl)-1,3-thiazol-2-yl]amino}phenol, SKI 2, 4-[[4-(4-chlorophenyl)-1,3-thiazol-2-yl]amino]phenol, CHEMBL1076555, MFCD00733553, phenol, 4-[[4-(4-chlorophenyl)-2-thiazolyl]amino]-, 3vzd, UUL, Ski ii (sphk-i2), Kinome_2076, AC1LFH8A, SPHK I2, SKI-2, Oprea1_828596, SCHEMBL526321, GTPL6041, CHEBI:92375, CTK8F1051, DTXSID90353799, ZFGXZJKLOFCECI-UHFFFAOYSA-N, HMS3268L05, HMS3650M12, HMS3653G15, HMS3677G03, KUC104644N, ZINC206382, EX-A2441, KS-00001D7V, 2038AH, 2718AH, BDBM50312869, BS0180, KSC-1-277, STL255710, AKOS002268816, CS-5598, MCULE-6825113025, SB19325, SKI II, >=98% (HPLC), solid, VZ28074, NCGC00092309-01, NCGC00092309-02, NCGC00092309-06, AK400222, CC-17495, HY-13822, ZB009515, N-aryl-4-aryl-1,3-thiazole-2-amine, 5, DB-047998, LS-193722, RT-015718, FT-0644394, S7176, ST45179418, SW123515-2, EC-000.2449, 4-[[4-(4-chlorophenyl)thiazol-2-yl]amino]phenol, A820778, C-18894, SR-01000946305, J-018326, SR-01000946305-1, BRD-K20755323-001-01-8, Phenol,4-[[4-(4-chlorophenyl)-2-thiazolyl]amino]-, SKI-11 compound, D00YNY, C15H11ClN2OS, CID753704, VPC-94075, ZINC00206382, B2226, A15988, Sphingosine kinase inhibitor (vascular disease), 2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole, 4-(4-(4-chloro-phenyl)thiazol-2-ylamino)phenol, C525025, 4-((4-(4-chloro-phenyl)thiazol-2-yl)amino)phenol, Sphingosine kinase inhibitor (vascular disease), University of Virgina,

Complexity	304
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	302.028g/mol
Formal Charge	0
Heavy Atom Count	20
Hydrogen Bond Acceptor Count	4
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	302.776g/mol
Monoisotopic Mass	302.028g/mol
Rotatable Bond Count	3
Topological Polar Surface Area	73.4A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	4.8

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302
Packing Group
Precautionary statements	P280-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number